RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis.

RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis.
复制标题

DOI:
10.3892/ijmm.2012.1129
复制
发表时间:
2012-12
影响因子:
5.4
通讯作者:
Nakajima T
Nakajima T
中科院分区:
医学3区
文献类型:
--
作者:
Yagishita N;Aratani S;Leach C;Amano T;Yamano Y;Nakatani K;Nishioka K;Nakajima T

文献摘要

参考文献

相似文献

类风湿性关节炎(RA)显著影响生活质量。我们最近克隆了一种与内质网相关降解(ERAD)途径有关的环型E3泛素连接酶synoviolin。滑膜因子在类风湿滑膜细胞中高度表达,可能参与RA的发病机制。抑制滑膜活动是治疗类风湿性关节炎的一种潜在有效的治疗方法。我们对小分子进行了高通量筛选,以寻找滑膜自泛素化活性的抑制剂。我们发现了两类小分子,分别命名为LS-101和LS-102,它们抑制滑膜小提琴的活性。LS-102选择性地抑制滑膜酶活性,而LS-101抑制广泛的ring型E3连接酶。此外,这些抑制剂抑制类风湿滑膜细胞的增殖,并显着降低RA小鼠模型的疾病严重程度。我们的研究结果表明,抑制滑膜鞘是治疗类风湿性关节炎的一种潜在的有效方法。
Rheumatoid arthritis (RA) significantly affects quality of life. We recently cloned synoviolin, a RING-type E3 ubiquitin ligase implicated in the endoplasmic reticulum-associated degradation (ERAD) pathway. Synoviolin is highly expressed in rheumatoid synovial cells and may be involved in the pathogenesis of RA. Inhibition of synoviolin activity is a potentially useful therapeutic approach for the treatment of RA. We conducted a high-throughput screen of small molecules to find inhibitors of synoviolin autoubiquitination activity. We identified two classes of small molecules, named LS-101 and LS-102, which inhibited synoviolin activity. LS-102 selectively inhibited synoviolin enzymatic activity, while LS-101 inhibited a broad array of RING-type E3 ligases. Moreover, these inhibitors suppressed the proliferation of rheumatoid synovial cells, and significantly reduced the severity of disease in a mouse model of RA. Our results suggest that inhibition of synoviolin is a potentially useful approach in the treatment of RA.
DOI: 10.1371/journal.pone.0013590
发表时间: 2010-10-25
期刊: PloS one
影响因子: 3.7
作者:
Hasegawa D;Fujii R;Yagishita N;Matsumoto N;Aratani S;Izumi T;Azakami K;Nakazawa M;Fujita H;Sato T;Araya N;Koike J;Tadokoro M;Suzuki N;Nagata K;Senoo H;Friedman SL;Nishioka K;Yamano Y;Itoh F;Nakajima T
通讯作者: Nakajima T
DOI: 10.1074/jbc.c000881200
发表时间: 2001-05-04
影响因子: 4.8
作者:
Hashizume, R;Fukuda, M;Ohta, T
通讯作者: Ohta, T
DOI: 10.1074/jbc.274.43.30963
发表时间: 1999-10-22
影响因子: 4.8
作者:
Moynihan, TP;Ardley, HC;Robinson, PA
通讯作者: Robinson, PA
DOI: 10.2165/11318290-000000000-00000
发表时间: 2009-01-01
期刊: DRUGS
影响因子: 11.5
作者:
Nurmohamed, Michael T.
通讯作者: Nurmohamed, Michael T.
DOI: 10.1101/gad.1096603
发表时间: 2003-10-01
影响因子: 10.5
作者:
Amano, T;Yamasaki, S;Nakajima, T
通讯作者: Nakajima, T